Prescription for curing type II diabetes and complications and preparation technology thereof

Abstract

The invention relates to a prescription for curing type II diabetes and complications and a preparation technology thereof. The prescription for curing the type II diabetes is prepared by defining, quantifying, extracting, separating or manually synthesizing traditional Chinese medicinal materials, such as radix puerariae, radix astragali, red sage roots, and the like and adding a chemical medicine of gliclazide by a solid dispersion technology. The prescription for curing the type II diabetes is a compound preparation by compounding Chinese and Western medicines and chemical medicines, can be prepared into preparation formulations of tablets, granules, capsules, dripping pills, and the like, can effectively cure the type II diabetes, improves the body immunity and can effectively delay the occurrence and the development of the diabetes complications. The preparation technology of the compound preparation has short technological flow, low production cost, rapid effectual action, unique prescription and preparation method thereof and remarkable treatment effect.

Description

Technical field

[0001] The invention is a new prescription combining traditional Chinese and western medicine composed of traditional Chinese medicinal materials and chemical medicines for treating type II diabetes and its preparation process. It is made by qualitatively and quantitatively extracting, separating, or artificially synthesizing the active ingredients in Chinese medicinal materials such as kudzu root, astragalus, and salvia miltiorrhiza, and then adding the chemical drug gliclazide. It is developed by solid dispersion technology and has a significant hypoglycemic effect. It can effectively improve human immunity, inhibit and effectively treat complications of diabetes. It belongs to the field of pharmaceutical preparations. Background technique

[0002] Diabetes is a group of clinical syndromes caused by the interaction of genetic and environmental factors. Absolute or relative insufficiency of insulin secretion and decreased sensitivity of target tissue cells...